Mixed group of people

Equal Access

Equal Access

Prioritize PD for the majority of patients, regardless of age, race or socio-economic background, by offering equal access to treatment options and patient support services.

Patient Candidacy

At least 78% of patients have no absolute medical or social contraindication for PD1

Learn more

Addressing Health Disparities

Opportunity exists to increase the use of PD among African & Hispanic Americans2

Learn more

Related Pages

Previous page

CMS continues to incentivize the use of home therapies through regulatory reform, with finalization of the ESRD treatment choices (ETC) model

ETC Model

Next page

Prioritize PD for the majority of ESKD patients

Patient Candidacy
References

  1. Mendelssohn DC, et al. A prospective evaluation of renal replacement therapy modality eligibility. Nephrol Dial Transplant. 2009;24(2):555-561

  2. United States Renal Data System. 2023 USRDS Annual Data Report: Epidemiology of kidney disease in the United States: End Stage Renal Disease: Chapter 1. Incidence, Prevalence, Patient Characteristics, and Treatment Modalities. National Institute of Diabetes and Digestive and Kidney Diseases.